Pages without language links

Jump to navigation Jump to search

The following pages do not link to other language versions.

Showing below up to 50 results in range #4,701 to #4,750.

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)

  1. Tang H, et al. J. Mol. Cell. Biol. (2017) cited as Ref 101 in DOI: 10.1038/s41392-020-0110-5
  2. Tang N, et al, J Thromb Haemost (2020), cited as Ref 60 in DOI:10.1007/s11886-020-01292-3
  3. Taniguchi K, et al. Nat. Rev. Immunol. (2018) cited as Ref 283 in DOI: 10.1038/s41392-020-0110-5
  4. Tanner Brumby pass complete to Sam Walker for 10 yds to the Mercr 45 (11/18/17)
  5. Tanner Brumby pass incomplete to Chandler Curtis (11/18/17)
  6. Tanner Brumby pass incomplete to Marquise Irvin (11/18/17)
  7. Tanner Brumby run for 2 yds to the Alab 39 (11/18/17)
  8. Tanner Brumby run for a loss of 1 yard to the Mercr 5 (11/18/17)
  9. Tanner Brumby run for a loss of 2 yards to the Alab 41 (11/18/17)
  10. Tanner Brumby run for no gain to the Alab 43 (11/18/17)
  11. Taoran G, et al, Chin J Internal Med (2020) cited as Ref 5 in DOI: 10.1080/22221751.2020.1735265
  12. Targeting cancer stem cell pathways for cancer therapy (DOI: 10.1038/s41392-020-0110-5)
  13. Tasian SK, et al. Front. Oncol. (2014) cited as Ref 352 in DOI: 10.1038/s41392-020-0110-5
  14. Tavien Feaster pass incomplete to Deon Cain (1/1/18)
  15. Tavien Feaster run for 4 yds to the Clem 30 (1/1/18)
  16. Tavien Feaster run for 6 yds to the Alab 12 (1/1/18)
  17. Tavien Feaster run for no gain to the Alab 18 (1/1/18)
  18. Tavien Feaster run for no gain to the Clem 16 (1/1/18)
  19. Taylor MD, et al. Cancer Cell (2005) cited as Ref 61 in DOI: 10.1038/s41392-020-0110-5
  20. Taylor MD, et al. Nat. Genet. (2002) cited as Ref 234 in DOI: 10.1038/s41392-020-0110-5
  21. Taylor RL, et al, J Clin Endocrinol Metab (1950), cited as Ref 22 in DOI:10.1007/s11886-020-01292-3
  22. Tcfc Information, Journal (2020), cited as Ref 19 in DOI: 10.1016/j.clim.2020.108427
  23. Tee Mitchell run for 12 yds to the Mercr 37 for a 1ST down (11/18/17)
  24. Tee Mitchell run for 1 yd to the Alab 34 (11/18/17)
  25. Tee Mitchell run for 1 yd to the Mercr 44 (11/18/17)
  26. Tee Mitchell run for 1 yd to the Mercr 8 (11/18/17)
  27. Tee Mitchell run for 21 yds to the Alab 40 for a 1ST down (11/18/17)
  28. Tee Mitchell run for 2 yds to the Alab 38 (11/18/17)
  29. Tee Mitchell run for 2 yds to the Alab 48 (11/18/17)
  30. Tee Mitchell run for 2 yds to the Mercr 39 (11/18/17)
  31. Tee Mitchell run for 3 yds to the 50 yard line (11/18/17)
  32. Tee Mitchell run for 3 yds to the Alab 35 (11/18/17)
  33. Tee Mitchell run for 3 yds to the Alab 40 (11/18/17)
  34. Tee Mitchell run for 3 yds to the Mercr 38 (11/18/17)
  35. Tee Mitchell run for 9 yds to the Alab 34 (11/18/17)
  36. Tee Mitchell run for a loss of 1 yard to the Alab 35 (11/18/17)
  37. Tee Mitchell run for a loss of 1 yard to the Mercr 35 (11/18/17)
  38. Tee Mitchell run for a loss of 2 yards to the Alab 42 (11/18/17)
  39. Tee Mitchell run for a loss of 2 yards to the Mercr 6 (11/18/17)
  40. Templeton SP, et al, Brain pathology (2008), cited as Ref 66 in DOI: 10.1186/s13054-020-02882-x
  41. Test Episode
  42. Test Page
  43. Test Segment
  44. Test Series
  45. Thayer SP, et al. Nature (2003) cited as Ref 598 in DOI: 10.1038/s41392-020-0110-5
  46. The Coronavirus Structure and Host (Section from DOI: 10.1080/09273948.2020.1738501)
  47. The Human Protein Atlas , et al, (Accessed April 1, 2020), cited as Ref 17 in DOI: 10.1007/s11886-020-01293-2
  48. The UniProt Consortium, et al, Nucleic Acids Res. (2019), cited as Ref 174 in DOI: 10.3390/v12020211
  49. The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing, China (DOI: 10.1186/s13613-020-00653-z)
  50. Theuns S, et al, Sci. Rep. (2018), cited as Ref 204 in DOI: 10.3390/v12020211

View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)